NCT07021989 2026-03-17ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin LymphomaUniversity of California, San FranciscoPhase 2 Not yet recruiting38 enrolled
NCT03646123 2025-08-28Clinical Trial of Brentuximab Vedotin in Classical Hodgkin LymphomaSeagen Inc.Phase 2 Terminated255 enrolled 29 charts